Stocks-BSX.US-Boston Scientific Corp

BSX.US Boston Scientific Corp

82.26 -1.24 (-1.49%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Stocks-BSX.US-Boston Scientific Corp
BSX.US Boston Scientific Corp
Trade

Overview

Prev Close 83.51
Day's Range 81.42 - 83.24
52 Week Range 48.29 - 83.96
Average Volume (3M) 5.55M
1-Year Return 55.15%
Beta0.7133
Market Cap 122.98B
P/E Ratio67.56
Revenue15.23B
EPS1.236
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Medical Specialties
CEO
Michael F. Mahoney, MBA
Employees
48,000

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Boston Scientific Corp's revenues increased by 12.29% and amounted to 14.24B. Net income increased by 128.08% to 1.59B. Net assets decreased by NaN to N/A and EPS increased from 0.45 to 1.07.
BSX.US's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/2401B2B3B4B5B
Gross Margin
62.04%
Net Profit Margin
13.68%
Operating Margin
16.46%
Return On Investment
6.52%
09/23
12/23
03/24
06/24
Total Revenue
3.53B
3.73B
3.86B
4.12B
Gross Profit
2.43B
2.58B
2.65B
2.85B
Operating Income
609M
617M
693M
799M
Net Income
504M
504M
493M
322M